Annual Short Term Debt
$83.70 M
-$5.70 M-6.38%
December 31, 2023
Summary
- As of February 6, 2025, VRTX annual short term debt is $83.70 million, with the most recent change of -$5.70 million (-6.38%) on December 31, 2023.
- During the last 3 years, VRTX annual short term debt has risen by +$41.30 million (+97.41%).
- VRTX annual short term debt is now -73.80% below its all-time high of $319.43 million, reached on December 31, 2016.
Performance
VRTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
N/A
September 30, 2024
Summary
- VRTX quarterly short term debt is not available.
Performance
VRTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
VRTX Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -6.4% | - |
3 y3 years | +97.4% | - |
5 y5 years | +1487.9% | - |
VRTX Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -6.4% | +4.4% | ||
5 y | 5-year | -6.4% | +115.8% | ||
alltime | all time | -73.8% | -100.0% |
Vertex Pharmaceuticals Incorporated Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $83.70 M(-6.4%) | $83.70 M(-6.4%) |
Dec 2022 | $89.40 M(+11.5%) | $89.40 M(+11.5%) |
Dec 2021 | $80.20 M(+89.2%) | $80.20 M(+89.2%) |
Dec 2020 | $42.40 M(+9.3%) | $42.40 M(+9.3%) |
Dec 2019 | $38.79 M(+636.0%) | $38.79 M(+636.0%) |
Dec 2018 | $5.27 M(-76.6%) | $5.27 M(-54.2%) |
Sep 2018 | - | $11.51 M(-23.6%) |
Jun 2018 | - | $15.06 M(-11.0%) |
Mar 2018 | - | $16.92 M(-24.9%) |
Dec 2017 | $22.53 M(-92.9%) | $22.53 M(+13.3%) |
Sep 2017 | - | $19.88 M(+9.4%) |
Jun 2017 | - | $18.18 M(-5.7%) |
Mar 2017 | - | $19.27 M(-94.0%) |
Dec 2016 | $319.43 M(+267.8%) | $319.43 M(+1.2%) |
Sep 2016 | - | $315.52 M(+32.0%) |
Jun 2016 | - | $239.02 M(+46.2%) |
Mar 2016 | - | $163.54 M(+88.3%) |
Dec 2015 | $86.84 M(+171.3%) | $86.84 M(+513.6%) |
Sep 2015 | - | $14.15 M(-75.1%) |
Jun 2015 | - | $56.79 M(+17.8%) |
Mar 2015 | - | $48.20 M(+50.6%) |
Dec 2014 | $32.01 M(+89.5%) | $32.01 M(+76.6%) |
Sep 2014 | - | $18.12 M(-8.0%) |
Jun 2014 | - | $19.71 M(+7.6%) |
Mar 2014 | - | $18.32 M(+8.5%) |
Dec 2013 | $16.89 M(+23.2%) | $16.89 M(+17.1%) |
Sep 2013 | - | $14.43 M(+35.3%) |
Jun 2013 | - | $10.66 M(+28.5%) |
Mar 2013 | - | $8.30 M(-39.4%) |
Dec 2012 | $13.71 M(>+9900.0%) | $13.71 M(>+9900.0%) |
Sep 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2011 | - | $98.42 M(+4.0%) |
Jun 2011 | - | $94.66 M(+2.8%) |
Mar 2011 | - | $92.10 M(-32.8%) |
Dec 2010 | $136.99 M(+327.1%) | $136.99 M(>+9900.0%) |
Sep 2010 | - | $0.00(0.0%) |
Mar 2010 | - | $0.00(-100.0%) |
Dec 2009 | $32.07 M(>+9900.0%) | $32.07 M(>+9900.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2007 | $20.00 M(-80.7%) | $20.00 M(0.0%) |
Sep 2007 | - | $20.00 M(-67.8%) |
Jun 2007 | - | $62.10 M(+37.3%) |
Mar 2007 | - | $45.23 M(-56.4%) |
Dec 2006 | $103.76 M | $103.76 M(+146.4%) |
Sep 2006 | - | $42.10 M(+798.1%) |
Sep 2004 | - | $4.69 M(0.0%) |
Jun 2004 | - | $4.69 M(>+9900.0%) |
Mar 2004 | - | $36.00 K(-99.3%) |
Sep 2003 | - | $4.84 M(+38.6%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2003 | - | $3.49 M(+154.0%) |
Mar 2003 | - | $1.37 M(-37.4%) |
Dec 2002 | $2.19 M(-52.1%) | $2.19 M(-26.1%) |
Sep 2002 | - | $2.97 M(-15.6%) |
Jun 2002 | - | $3.52 M(-10.4%) |
Mar 2002 | - | $3.93 M(-14.2%) |
Dec 2001 | $4.58 M(-9.7%) | $4.58 M(+0.4%) |
Sep 2001 | - | $4.56 M(+126.3%) |
Jun 2001 | - | $2.02 M(-7.8%) |
Mar 2001 | - | $2.19 M(-56.9%) |
Dec 2000 | $5.07 M(+114.3%) | $5.07 M(-96.9%) |
Sep 2000 | - | $163.80 M(+7331.9%) |
Jun 2000 | - | $2.20 M(-3.0%) |
Mar 2000 | - | $2.27 M(-4.0%) |
Dec 1999 | $2.37 M(-15.5%) | $2.37 M(-5.4%) |
Sep 1999 | - | $2.50 M(-3.8%) |
Jun 1999 | - | $2.60 M(-3.7%) |
Mar 1999 | - | $2.70 M(-3.6%) |
Dec 1998 | $2.80 M(+12.0%) | $2.80 M(0.0%) |
Sep 1998 | - | $2.80 M(+3.7%) |
Jun 1998 | - | $2.70 M(+8.0%) |
Mar 1998 | - | $2.50 M(0.0%) |
Dec 1997 | $2.50 M(-13.8%) | $2.50 M(-7.4%) |
Sep 1997 | - | $2.70 M(-3.6%) |
Jun 1997 | - | $2.80 M(0.0%) |
Mar 1997 | - | $2.80 M(-3.4%) |
Dec 1996 | $2.90 M(+38.1%) | $2.90 M(+16.0%) |
Sep 1996 | - | $2.50 M(+8.7%) |
Jun 1996 | - | $2.30 M(+9.5%) |
Mar 1996 | - | $2.10 M(0.0%) |
Dec 1995 | $2.10 M(+23.5%) | $2.10 M(+10.5%) |
Sep 1995 | - | $1.90 M(+5.6%) |
Jun 1995 | - | $1.80 M(+5.9%) |
Mar 1995 | - | $1.70 M(0.0%) |
Dec 1994 | $1.70 M(-5.6%) | $1.70 M(+6.3%) |
Sep 1994 | - | $1.60 M(0.0%) |
Jun 1994 | - | $1.60 M(0.0%) |
Mar 1994 | - | $1.60 M(-11.1%) |
Dec 1993 | $1.80 M(0.0%) | $1.80 M(-5.3%) |
Sep 1993 | - | $1.90 M(-5.0%) |
Jun 1993 | - | $2.00 M(+5.3%) |
Mar 1993 | - | $1.90 M(+5.6%) |
Dec 1992 | $1.80 M(+50.0%) | $1.80 M(+5.9%) |
Sep 1992 | - | $1.70 M(+13.3%) |
Jun 1992 | - | $1.50 M(+15.4%) |
Mar 1992 | - | $1.30 M(+8.3%) |
Dec 1991 | $1.20 M(+50.0%) | $1.20 M(+9.1%) |
Sep 1991 | - | $1.10 M(+10.0%) |
Jun 1991 | - | $1.00 M(+25.0%) |
Dec 1990 | $800.00 K | $800.00 K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual short term debt?
- What is the all time high annual short term debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual short term debt year-on-year change?
- What is the all time high quarterly short term debt for Vertex Pharmaceuticals Incorporated?
What is Vertex Pharmaceuticals Incorporated annual short term debt?
The current annual short term debt of VRTX is $83.70 M
What is the all time high annual short term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual short term debt is $319.43 M
What is Vertex Pharmaceuticals Incorporated annual short term debt year-on-year change?
Over the past year, VRTX annual short term debt has changed by -$5.70 M (-6.38%)
What is the all time high quarterly short term debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly short term debt is $319.43 M